Alignment Healthcare, Inc. (ALHC)

$8.93

-0.43

(-4.59%)▲

Market is closed - opens 7 PM, 29 Jul 2024

Performance

  • $8.77
    $9.64
    $8.93
    downward going graph

    1.79%

    Downside

    Day's Volatility :9.02%

    Upside

    7.37%

    downward going graph
  • $4.46
    $10.16
    $8.93
    downward going graph

    50.06%

    Downside

    52 Weeks Volatility :56.1%

    Upside

    12.11%

    downward going graph

Returns

PeriodAlignment Healthcare, Inc.Sector (Health Care)Index (Russel 2000)
3 Months
79.65%
6.5%
0.0%
6 Months
33.71%
7.1%
0.0%
1 Year
54.46%
9.8%
0.0%
3 Years
-52.39%
14.2%
-20.2%

Highlights

Market Capitalization
1.8B
Book Value
$0.69
Earnings Per Share (EPS)
-0.84
Wall Street Target Price
8.3
Profit Margin
-7.81%
Operating Margin TTM
-6.49%
Return On Assets TTM
-12.03%
Return On Equity TTM
-88.43%
Revenue TTM
2.0B
Revenue Per Share TTM
10.73
Quarterly Revenue Growth YOY
43.1%
Gross Profit TTM
184.3M
EBITDA
-111.5M
Diluted Eps TTM
-0.84
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-0.67
EPS Estimate Next Year
-0.52
EPS Estimate Current Quarter
-0.22
EPS Estimate Next Quarter
-0.11

Analyst Recommendation

Buy
    61%Buy
    33%Hold
    5%Sell
Based on 18 Wall street analysts offering stock ratings for Alignment Healthcare, Inc.(by analysts ranked 0 to 5 stars)
Based on 18 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
11
11
12
Hold
6
6
5
Sell
1
1
00

Analyst Forecast

What analysts predicted

Downside of 7.05%

Current $8.93
Target $8.30

Company Financials

FY19Y/Y Change
Revenue
757.0M
-
Net Income
-59.3M
-
Net Profit Margin
-7.83%
-
FY20Y/Y Change
Revenue
959.2M
↑ 26.72%
Net Income
-39.1M
↓ 34.0%
Net Profit Margin
-4.08%
↑ 3.75%
FY21Y/Y Change
Revenue
1.2B
↑ 21.74%
Net Income
-213.0M
↑ 444.3%
Net Profit Margin
-18.24%
↓ 14.16%
FY22Y/Y Change
Revenue
1.4B
↑ 22.81%
Net Income
-149.6M
↓ 29.73%
Net Profit Margin
-10.43%
↑ 7.81%
FY23Y/Y Change
Revenue
1.8B
↑ 27.16%
Net Income
-148.0M
↓ 1.08%
Net Profit Margin
-8.12%
↑ 2.31%
Q4 FY22Q/Q Change
Revenue
361.8M
↑ 0.41%
Net Income
-57.0M
↑ 41.61%
Net Profit Margin
-15.75%
↓ 4.58%
Q1 FY23Q/Q Change
Revenue
439.2M
↑ 21.38%
Net Income
-37.4M
↓ 34.43%
Net Profit Margin
-8.51%
↑ 7.24%
Q2 FY23Q/Q Change
Revenue
462.4M
↑ 5.29%
Net Income
-28.5M
↓ 23.8%
Net Profit Margin
-6.16%
↑ 2.35%
Q3 FY23Q/Q Change
Revenue
456.7M
↓ 1.23%
Net Income
-35.0M
↑ 23.07%
Net Profit Margin
-7.67%
↓ 1.51%
Q4 FY23Q/Q Change
Revenue
465.4M
↑ 1.9%
Net Income
-47.2M
↑ 34.7%
Net Profit Margin
-10.14%
↓ 2.47%
Q1 FY24Q/Q Change
Revenue
628.6M
↑ 35.07%
Net Income
-46.5M
↓ 1.46%
Net Profit Margin
-7.4%
↑ 2.74%
FY19Y/Y Change
Total Assets
193.4M
-
Total Liabilities
272.2M
-
FY20Y/Y Change
Total Assets
338.5M
↑ 74.99%
Total Liabilities
307.9M
↑ 13.13%
FY21Y/Y Change
Total Assets
630.9M
↑ 86.38%
Total Liabilities
324.8M
↑ 5.5%
FY22Y/Y Change
Total Assets
633.9M
↑ 0.47%
Total Liabilities
394.6M
↑ 21.46%
FY23Y/Y Change
Total Assets
591.9M
↓ 6.62%
Total Liabilities
433.8M
↑ 9.95%
Q4 FY22Q/Q Change
Total Assets
633.9M
↓ 18.48%
Total Liabilities
394.6M
↓ 21.93%
Q1 FY23Q/Q Change
Total Assets
761.8M
↑ 20.18%
Total Liabilities
537.8M
↑ 36.31%
Q2 FY23Q/Q Change
Total Assets
783.5M
↑ 2.86%
Total Liabilities
572.4M
↑ 6.44%
Q3 FY23Q/Q Change
Total Assets
770.8M
↓ 1.63%
Total Liabilities
581.2M
↑ 1.53%
Q4 FY23Q/Q Change
Total Assets
591.9M
↓ 23.21%
Total Liabilities
433.8M
↓ 25.36%
Q1 FY24Q/Q Change
Total Assets
633.2M
↑ 6.99%
Total Liabilities
501.2M
↑ 15.54%
FY19Y/Y Change
Operating Cash Flow
9.2M
-
Investing Cash Flow
-10.2M
-
Financing Cash Flow
52.7M
-
FY20Y/Y Change
Operating Cash Flow
7.6M
↓ 17.89%
Investing Cash Flow
-16.4M
↑ 59.75%
Financing Cash Flow
130.1M
↑ 147.08%
FY21Y/Y Change
Operating Cash Flow
-78.8M
↓ 1141.87%
Investing Cash Flow
-20.8M
↑ 27.25%
Financing Cash Flow
360.1M
↑ 176.76%
FY22Y/Y Change
Operating Cash Flow
-45.4M
↓ 42.33%
Investing Cash Flow
-28.2M
↑ 35.56%
Financing Cash Flow
16.6M
↓ 95.39%
Q4 FY22Q/Q Change
Operating Cash Flow
-149.3M
↓ 241.99%
Investing Cash Flow
-8.1M
↓ 0.26%
Financing Cash Flow
-527.0K
↓ 103.06%
Q1 FY23Q/Q Change
Operating Cash Flow
85.1M
↓ 157.02%
Investing Cash Flow
-110.4M
↑ 1262.13%
Financing Cash Flow
30.0K
↓ 105.69%
Q2 FY23Q/Q Change
Operating Cash Flow
37.2M
↓ 56.32%
Investing Cash Flow
-26.2M
↓ 76.27%
Financing Cash Flow
30.0K
↑ 0.0%

Technicals Summary

Sell

Neutral

Buy

Alignment Healthcare, Inc. is currently in a neutral trading position according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Alignment Healthcare, Inc.
Alignment Healthcare, Inc.
23.32%
33.71%
54.46%
-52.39%
-45.93%
The Cigna Corp
The Cigna Corp
1.06%
14.55%
17.36%
49.34%
103.92%
Unitedhealth Group Incorporated
Unitedhealth Group Incorporated
15.63%
11.22%
10.17%
35.34%
121.27%
Cvs Health Corporation
Cvs Health Corporation
-3.27%
-19.66%
-21.9%
-29.23%
5.6%
Humana Inc.
Humana Inc.
7.01%
6.97%
-13.79%
-17.31%
39.56%
Elevance Health, Inc
Elevance Health, Inc
-3.8%
6.25%
9.46%
35.81%
71.35%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Alignment Healthcare, Inc.
Alignment Healthcare, Inc.
NA
NA
NA
-0.67
-0.88
-0.12
NA
0.69
The Cigna Corp
The Cigna Corp
28.1
28.1
0.89
28.5
0.09
0.03
0.02
144.9
Unitedhealth Group Incorporated
Unitedhealth Group Incorporated
37.05
37.05
1.24
25.54
0.16
0.07
0.02
102.02
Cvs Health Corporation
Cvs Health Corporation
10.27
10.27
1.0
6.43
0.1
0.03
0.05
59.08
Humana Inc.
Humana Inc.
23.82
23.82
1.64
16.34
0.12
0.05
0.01
133.86
Elevance Health, Inc
Elevance Health, Inc
18.22
18.22
1.14
37.26
0.17
0.06
0.01
181.94
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Alignment Healthcare, Inc.
Alignment Healthcare, Inc.
Buy
$1.8B
-45.93%
NA
-7.81%
The Cigna Corp
The Cigna Corp
Buy
$97.2B
103.92%
28.1
1.77%
Unitedhealth Group Incorporated
Unitedhealth Group Incorporated
Buy
$515.2B
121.27%
37.05
3.66%
Cvs Health Corporation
Cvs Health Corporation
Buy
$73.5B
5.6%
10.27
2.04%
Humana Inc.
Humana Inc.
Buy
$46.5B
39.56%
23.82
1.82%
Elevance Health, Inc
Elevance Health, Inc
Buy
$120.8B
71.35%
18.22
3.9%

Insights on Alignment Healthcare, Inc.

  • Increasing Revenue

    Revenue is up for the last 3 quarters, 456.70M → 628.60M (in $), with an average increase of 13.9% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -47.20M → -46.52M (in $), with an average increase of 1.5% per quarter

  • Vs CI

    In the last 3 years, The Cigna Corp has given 49.3% return, outperforming this stock by 101.7%

Institutional Holdings

  • General Atlantic Llc

    31.90%

  • Warburg Pincus LLC

    9.37%

  • FMR Inc

    8.89%

  • Vanguard Group Inc

    4.83%

  • T. Rowe Price Investment Management,Inc.

    4.34%

  • Deerfield Management Co

    4.33%

Company Information

alignment healthcare is redefining the business of health care by shifting the focus from payments to people. we’ve created a new model for health care delivery that cuts costs and improves lives by unraveling the inefficiencies of the current system to drive patients, providers and payers toward a common goal of wellness. harnessing best practices from medicare advantage, our innovative data-management technology allows us to commit to caring for seniors and those who need it most: the chronically ill and frail. with offices and care centers across the country, alignment healthcare provides partners and patients with customized care and service where they need it and when they need it, including clinical coordination, risk management and technology facilitation. alignment healthcare offers hmo plan options to california residents through the alignment health plan, and partners with select health plans in north carolina and florida to help deliver better benefits at lower costs. for mo

Organization
Alignment Healthcare, Inc.
Employees
1536
CEO
Mr. John E. Kao
Industry
Healthcare

Discover More

FAQs